Kestrel Capital, formerly known as Nanyang Ventures, is a private equity firm that focuses on investing in Australia-and New Zealand-based companies. The firm targets venture, direct secondaries, growth and turnaround opportunities in a wide variety of sectors, including healthcare IT, manufacturing and logistics. Kestrel Capital avoids investments in biotechnolgy, early stage R&D, property and retail.
Direct Secondaries
3 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.